Syncope is a common reason for consultations and hospitali-zations. A diagnosis is established in 50 % of cases with the initial assessment. It can also be used to stratify the risk of cardiovascular events or recurrence, and their potentially fatal consequences. This stratification, based on European and American guidelines, is essential for guiding management. Various predictive scores exist, including the Canadian Syncope Risk Score (CSRS), which assesses the risk of serious events within 30 days. The CSRS has limitations in both emergency and outpatient settings. Current guidelines do not include specific scores, highlighting the importance of clinical judgment and the initial assessment for risk stratification.